Old Fimiston, tried a bit of every thing, dot coms, mining, and now a biotech company. This time they could be on a winner, acquiring InfaMed early this year. The Funhaler, a space device for childhood asthma could be on market as early as next year. Xel has a market cap of about 5 or 6 million dollars. XELOA will give excellent leaverage to company that could multiply in share price. Like they say do your own research and remember the risks, especially Biotechs I have only used my betting money on this one.
